🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Tablet(s) Serving Size
60 Servings
Botanical with Nutrients Product Type
0% Evidence Coverage

Supplement Facts — Evidence Check

Calcium
41 mg (3% DV)
Andrographis Aerial Parts Extract
300 mg
Andrographis
100 mg

Other Ingredients

Microcrystalline Cellulose Dibasic Calcium Phosphate Stearic Acid Modified Cellulose Gum Hydroxypropyl Cellulose Silica

Label Claims — Verification

All Other
Structure/Function
All Other (99% of products) Structure/Function (85% of products) Nutrient (54% of products) Approved Health (3% of products)

Target Groups

Adult (18 - 50 Years) Women (not pregnant or lactating)

Product Information

📋 Directions for Use

Suggested use: 1 tablet twice daily.

⚠️ Warnings & Precautions

Warning: not for use by women who are pregnant, may become pregnant or breastfeeding.

Do not use if either tamper-evident seal is broken or missing.

Keep out of the reach of children.

🧪 Formulation Notes

Andrographis paniculata is an herb commonly used in China, India and other countries in subtropical and Southeast Asia. Both the fresh and dried leaves, as well as the fresh juice of the whole plant, have been used in a variety of cultures. In traditional Chinese herbalism, andrographis is used to support healthy digestive, cardiovascular, and urinary systems. In Sweden, andrographis has been used for more than 10 years as a primary herb for the winter season.

Additional Information

Approved by Michael Tierra L.Ac, O.M.D Michael Tierra

Store in a cool, dry place.

Product Details

UPC / SKU 0 21078 10487 2
DSLD Entry Date 2025-02-23
Product Type Botanical with Nutrients
Form Tablet or Pill
DSLD ID 322751
Data Updated 2026-04-11

Research Evidence

849 Research Sources
56 Avg Quality Score
450 Meta Analysis
152 Rct
137 Systematic Review
73 Clinical Trial
11 Regulatory Source
7 Other
7 Guideline
3 Openfda Safety
2 Cochrane Review
2 Observational
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023
A Dietary sodium, sodium-to-potassium ratio, and risk of stroke: A systematic review and nonlinear dose-response meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2019
A The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: A systematic review and meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2021
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021
View all evidence for Electrolytes →

Compare Similar Products

View all Electrolytes products →